OncoSec reports preliminary Phase I data for ImmunoPulse IL-12 in TNBC

OncoSec Medical Inc. (NASDAQ:ONCS) reported preliminary data from two evaluable heavily pretreated patients with metastatic triple-negative breast cancer (TNBC) in the Phase

Read the full 224 word article

User Sign In